Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Appointed director
Director departure

NANOMIX Corp (BTHE) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/05/2021 8-K/A Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "BUSINESS OF THE COMPANY",
"RISK FACTORS OF THE COMPANY"
08/27/2021 8-K/A Quarterly results
04/30/2018 8-K/A Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity ...
Docs: "Audited Financial Statements of CureDM Group, LLC for the years ended December 31, 2017 and 2016",
"Pro-Forma Financial Information"
02/12/2018 8-K/A Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
11/01/2017 8-K/A Quarterly results
07/06/2016 8-K/A Form 8-K/A - Current report [Amend]
05/12/2016 8-K/A Form 8-K/A - Current report [Amend]
03/02/2016 8-K/A Form 8-K/A - Current report [Amend]
10/30/2015 8-K/A Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Letter Amendment by and between Boston Therapeutics, Inc. and CJY Holdings Limited"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy